APA (7th ed.) Citation

Alrifai, D., Harper-Wynne, C., Jyothirmayi, R., & Burcombe, R. (2016). Decision-making for Adjuvant Chemotherapy in the Absence of Genomic Testing for Breast Cancer Patients with ‘Intermediate’ Risk of Mortality at 10 Years. Clinical Oncology, 28(5), e2. https://doi.org/10.1016/j.clon.2016.01.017

Chicago Style (17th ed.) Citation

Alrifai, D., C. Harper-Wynne, R. Jyothirmayi, and R. Burcombe. "Decision-making for Adjuvant Chemotherapy in the Absence of Genomic Testing for Breast Cancer Patients with ‘Intermediate’ Risk of Mortality at 10 Years." Clinical Oncology 28, no. 5 (2016): e2. https://doi.org/10.1016/j.clon.2016.01.017.

MLA (9th ed.) Citation

Alrifai, D., et al. "Decision-making for Adjuvant Chemotherapy in the Absence of Genomic Testing for Breast Cancer Patients with ‘Intermediate’ Risk of Mortality at 10 Years." Clinical Oncology, vol. 28, no. 5, 2016, p. e2, https://doi.org/10.1016/j.clon.2016.01.017.